Drug tied to meningitis reached state, CDC says
Four health-care facilities in California received lots of a drug that has been linked to an outbreak of a rare type of meningitis, but none is in the Sacramento region.
The Centers for Disease Control and Prevention on Friday released a list of facilities nationwide that received lots of methylprednisolone acetate from New England Compounding Center in Framingham, Mass., that were recalled last week.
The four California facilities receiving the drug are in Visalia, Encino, Ukiah and Palmdale.
To date, 47 cases of fungal meningitis in seven states have been linked to the injectable steroid medication, and five people have died, according to the CDC.
The majority of the cases, 29, have been reported in Tennessee, with three deaths there. Cases also have been reported in Florida, Indiana, Maryland, Michigan, North Carolina and Virginia.
The patients are thought to have been infected by a fungus that contaminated the steroid drug, which is administered to treat back pain.